BG103852A - Cog-2 selective carprophene for the treatment of pains and inflammations in dogs - Google Patents

Cog-2 selective carprophene for the treatment of pains and inflammations in dogs

Info

Publication number
BG103852A
BG103852A BG103852A BG10385299A BG103852A BG 103852 A BG103852 A BG 103852A BG 103852 A BG103852 A BG 103852A BG 10385299 A BG10385299 A BG 10385299A BG 103852 A BG103852 A BG 103852A
Authority
BG
Bulgaria
Prior art keywords
cog
activity
acids
inhibition
dogs
Prior art date
Application number
BG103852A
Other languages
Bulgarian (bg)
English (en)
Inventor
Kristin LUNDI
Anthony RICKETTS
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of BG103852A publication Critical patent/BG103852A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
BG103852A 1997-05-05 1999-11-03 Cog-2 selective carprophene for the treatment of pains and inflammations in dogs BG103852A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05
PCT/IB1998/000662 WO1998050033A1 (fr) 1997-05-05 1998-05-01 Carprofene inhibant selectivement cox-2 et utilise dans le traitement de la douleur et des inflammations chez les chiens

Publications (1)

Publication Number Publication Date
BG103852A true BG103852A (en) 2000-06-30

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103852A BG103852A (en) 1997-05-05 1999-11-03 Cog-2 selective carprophene for the treatment of pains and inflammations in dogs

Country Status (32)

Country Link
EP (1) EP0988034A1 (fr)
JP (1) JP2000513020A (fr)
KR (2) KR20040004406A (fr)
CN (1) CN1255059A (fr)
AP (1) AP9801234A0 (fr)
AR (2) AR011726A1 (fr)
AU (1) AU6932198A (fr)
BG (1) BG103852A (fr)
BR (1) BR9808720A (fr)
CA (1) CA2288759A1 (fr)
DZ (1) DZ2479A1 (fr)
EA (1) EA003696B1 (fr)
GT (1) GT199800063A (fr)
HR (1) HRP980244A2 (fr)
HU (1) HUP0001286A3 (fr)
ID (1) ID21311A (fr)
IL (1) IL132570A0 (fr)
IS (1) IS5220A (fr)
MA (1) MA26491A1 (fr)
NO (1) NO995389L (fr)
NZ (1) NZ500183A (fr)
OA (1) OA11213A (fr)
PA (1) PA8450601A1 (fr)
PE (1) PE72599A1 (fr)
PL (1) PL337003A1 (fr)
SK (1) SK148199A3 (fr)
TN (1) TNSN98059A1 (fr)
TW (1) TW590773B (fr)
UY (1) UY24989A1 (fr)
WO (1) WO1998050033A1 (fr)
YU (1) YU55899A (fr)
ZA (1) ZA983722B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
US6506785B2 (en) 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
CA2347365A1 (fr) * 1998-10-23 2000-05-04 Merck Frosst Canada & Co. Produit de combinaison comprenant un ligand de prostaglandine de type e et un inhibiteur selectif de cox-2, et procedes d'utilisation dudit produit
EP1637137A3 (fr) * 1999-03-10 2006-07-05 G.D. Searle LLC Méthode et composition se rapportant à l'administration d'un inhibiteure de la cyclooxygénase-2 aux animaux
AU1592901A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
JP2004521856A (ja) * 2000-05-15 2004-07-22 メルク フロスト カナダ アンド カンパニー Ｃｏｘ−２選択的阻害剤およびトロンボキサン阻害剤を用いる併用療法ならびにそのための組成物
AU6837701A (en) 2000-06-13 2001-12-24 American Home Prod Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
US20020106707A1 (en) 2000-08-07 2002-08-08 Marnett Lawrence J. Compositions and methods for detecting and quantifying COX-2 activity and anandamide metabolites
US20040209959A1 (en) * 2001-07-16 2004-10-21 Edward Hogestatt Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation
PT1534305E (pt) 2003-05-07 2007-02-28 Osteologix As Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis
WO2005009436A1 (fr) * 2003-07-31 2005-02-03 Pharmacia & Upjohn Company Llc Formulation dispersable d'un agent anti-inflammatoire
EP1940380A2 (fr) * 2005-05-20 2008-07-09 Pfizer Limited Combinaisons synergiques des medicaments anti-inflammatoires non steroidiens avec des ligands alpha-2 delta
US8535713B2 (en) 2007-04-04 2013-09-17 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
US8951570B2 (en) 2007-04-26 2015-02-10 Sigmoid Pharma Limited Manufacture of multiple minicapsules
JP5640079B2 (ja) 2009-05-18 2014-12-10 シグモイド・ファーマ・リミテッドＳｉｇｍｏｉｄ Ｐｈａｒｍａ Ｌｉｍｉｔｅｄ 油滴含有組成物
BR112012002963A2 (pt) 2009-08-12 2017-10-24 Sigmoid Pharma Ltd composições imunomoduladoras compreendendo uma matriz de polímero e uma fase oleosa
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
CA2941008C (fr) 2014-03-06 2022-07-26 Aratana Therapeutics, Inc. Compositions de grapiprant et ses procedes d'utilisation
EP3215127B1 (fr) 2014-11-07 2020-10-28 Sublimity Therapeutics Limited Compositions comprenant de la cyclosporine
BR112017014750A2 (pt) * 2015-01-09 2018-06-19 Jaguar Animal Health métodos para tratamento de diarreia em animais de estimação
CN115335046A (zh) * 2020-03-25 2022-11-11 思研（Sri）国际顾问与咨询公司 脂肪氧合酶抑制剂
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (fr) * 1987-02-03 1993-07-06 Alberto Ferro Solutions de micelles mixtes

Also Published As

Publication number Publication date
WO1998050033A1 (fr) 1998-11-12
HUP0001286A3 (en) 2000-12-28
AP9801234A0 (en) 1999-11-04
HUP0001286A2 (hu) 2000-11-28
KR20010012300A (ko) 2001-02-15
DZ2479A1 (fr) 2003-02-01
PA8450601A1 (es) 2000-05-24
MA26491A1 (fr) 2004-12-20
JP2000513020A (ja) 2000-10-03
EA003696B1 (ru) 2003-08-28
BR9808720A (pt) 2000-07-11
EP0988034A1 (fr) 2000-03-29
HRP980244A2 (en) 1999-02-28
TNSN98059A1 (fr) 2005-03-15
PE72599A1 (es) 1999-08-12
SK148199A3 (en) 2001-09-11
CN1255059A (zh) 2000-05-31
AU6932198A (en) 1998-11-27
AR011726A1 (es) 2000-08-30
ZA983722B (en) 1999-11-04
ID21311A (id) 1999-05-20
PL337003A1 (en) 2000-07-31
GT199800063A (es) 1999-10-26
NO995389L (no) 2000-01-04
NZ500183A (en) 2002-04-26
OA11213A (en) 2003-07-14
EA199900895A1 (ru) 2000-06-26
NO995389D0 (no) 1999-11-04
CA2288759A1 (fr) 1998-11-12
IS5220A (is) 1999-10-19
AR039628A2 (es) 2005-03-02
YU55899A (sh) 2003-08-29
KR20040004406A (ko) 2004-01-13
TW590773B (en) 2004-06-11
UY24989A1 (es) 2001-10-25
IL132570A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
BG103852A (en) Cog-2 selective carprophene for the treatment of pains and inflammations in dogs
DE69805846T2 (de) Verwendung von 3-benzoylphenylessigsäuren, deren estern oder amiden zur behandlung von glc1a glaukom
DE59711321D1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
CA2241981A1 (fr) Procede d'inhibition du photoviellissement de la peau
ATE407573T1 (de) Verwendung von lokal verabreichten lysine zur verbesserung der vaskularen funktion
DE69634951D1 (de) Topische verwendung von betulinsäure zur behandlung bösartiger melanome
WO1999046279A3 (fr) INHIBITEURS DE LA 17β-HYDROXYSTEROIDE DESHYDROGENASE DU TYPE 5 ET DU TYPE 3 ET METHODES D'UTILISATION ASSOCIEES
CA2168963A1 (fr) Agent preventif et curatif contre les maladies provoquees par la formation de fibrinoides ou de thrombus dans les poumons et modele animal pour ces maladies
DE69526183T2 (de) 3-benzoylphenylessigsäure-derivate enthaltende topische zusammensetzungen zur behandlung der ophthalmischen entzündungserkrankungen
WO1994020062A3 (fr) Balanoides utilisables comme inhibiteurs de la proteine kinase c
ATE321548T1 (de) Verwendung von statin zur behandlung von hauterkrankungen
DE69613693T2 (de) 2-heteroarylalkenylderivate der cyclopentano-heptan(heptaen)säure als therapeutisches mittel zur behandlung des erhöhten augeninnendruckes
ES2162051T3 (es) Preparacion dermatologica para tratar queratosis actinicas.
DE69611452T2 (de) Benzothiophenderivate
ATE198751T1 (de) Azoderivate von 5-aminosalicylsäure zur behandlung von enzündlichen darmerkrankungen
NO20006506D0 (no) Anvendelse av valproinsyreanalog for behandlingen og forebyggelsen av migrene og affektive sykdommer
FR2755011B1 (fr) Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles et/ou les dommages aigus induits par les rayonnements u.v.
ZA978400B (en) Use of inhibitors of the activity of retinoic acid to promote healing.
DE69518073T2 (de) Pyrazol-Carbonsäurederivate als Mittel zur Bekämpfung von Pflanzenkrankheiten
CA2362888A1 (fr) Utilisation d'acides r-aryl-propioniques pour la production de medicaments, pour le traitement de maladies touchant l'homme et l'animal et sur lesquelles l'inhibition de l'activation du facteur de transcription nf-kb peut exercer une influence d'un point de vue therapeutique
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
MX26142A (es) Derivados de acido benzoico para tratar enfermedades relacionadas con leucotrieno.
ATE238796T1 (de) Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen
HUP9902417A2 (hu) Alfa-ketoészterek, és alfa-ketoamidok acilezett enol-származékai